PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America; Bloomberg School of Public Health, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.\', \'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.\', \'Fundacion Valle de Lili, Cali, Colombia.\', \'Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.\', \'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America. Electronic address: cpardov1@jhmi.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0022-510X(21)00211-210.1016/j.jns.2021.117517
?:hasPublicationType
?:journal
  • Journal of the neurological sciences
is ?:pmid of
?:pmid
?:pmid
  • 34090021
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.002
?:rankingScore_hIndex
  • 120
is ?:relation_isRelatedTo_publication of
?:title
  • Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all